| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 127.86B | 142.26B | 159.51B | 174.97B | 162.53B |
| Gross Profit | 31.27B | 30.27B | 27.38B | 31.93B | 34.29B |
| EBITDA | 19.13B | 18.07B | 15.71B | 18.05B | 21.53B |
| Net Income | 15.64B | 4.15B | -8.50B | 5.68B | 6.70B |
Balance Sheet | |||||
| Total Assets | 195.53B | 176.37B | 205.82B | 202.18B | 200.19B |
| Cash, Cash Equivalents and Short-Term Investments | 34.52B | 24.53B | 27.24B | 17.11B | 18.17B |
| Total Debt | 2.88B | 3.42B | 10.70B | 10.23B | 7.89B |
| Total Liabilities | 32.97B | 38.06B | 64.24B | 53.19B | 53.16B |
| Stockholders Equity | 159.24B | 135.38B | 139.04B | 146.07B | 144.48B |
Cash Flow | |||||
| Free Cash Flow | 13.96B | 7.15B | 12.77B | 1.47B | 2.73B |
| Operating Cash Flow | 20.21B | 13.93B | 19.81B | 10.85B | 11.33B |
| Investing Cash Flow | -5.68B | -5.08B | -6.26B | -10.17B | -11.70B |
| Financing Cash Flow | -5.17B | -11.89B | -4.01B | -2.34B | -5.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥112.73B | 7.03 | 9.19% | 3.33% | -10.12% | 276.36% | |
78 Outperform | ¥181.40B | 15.59 | ― | 2.84% | 4.10% | 5.25% | |
77 Outperform | ¥177.02B | 11.04 | ― | 3.50% | 4.44% | 4.49% | |
77 Outperform | ¥113.42B | 8.38 | ― | 3.72% | 4.49% | 27.96% | |
74 Outperform | ¥99.04B | 10.07 | ― | 1.24% | 13.15% | 122.76% | |
69 Neutral | ¥104.36B | 6.35 | ― | 4.15% | 6.68% | 97.70% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |